Literature DB >> 16550326

Molecular mechanisms involved in T cell migration across the blood-brain barrier.

B Engelhardt1.   

Abstract

In the healthy individuum lymphocyte traffic into the central nervous system (CNS) is very low and tightly controlled by the highly specialized blood-brain barrier (BBB). In contrast, under inflammatory conditions of the CNS such as in multiple sclerosis or in its animal model experimental autoimmune encephalomyelitis (EAE) circulating lymphocytes and monocytes/macrophages readily cross the BBB and gain access to the CNS leading to edema, inflammation and demyelination. Interaction of circulating leukocytes with the endothelium of the blood-spinal cord and blood-brain barrier therefore is a critical step in the pathogenesis of inflammatory diseases of the CNS. Leukocyte/endothelial interactions are mediated by adhesion molecules and chemokines and their respective chemokine receptors. We have developed a novel spinal cord window preparation, which enables us to directly visualize CNS white matter microcirculation by intravital fluorescence videomicroscopy. Applying this technique of intravital fluorescence videomicroscopy we could provide direct in vivo evidence that encephalitogenic T cell blasts interact with the spinal cord white matter microvasculature without rolling and that alpha4-integrin mediates the G-protein independent capture and subsequently the G-protein dependent adhesion strengthening of T cell blasts to microvascular VCAM-1. LFA-1 was found to neither mediate the G-protein independent capture nor the G- protein dependent initial adhesion strengthening of encephalitogenic T cell blasts within spinal cord microvessel, but was rather involved in T cell extravasation across the vascular wall into the spinal cord parenchyme. Our observation that G-protein mediated signalling is required to promote adhesion strengthening of encephalitogenic T cells on BBB endothelium in vivo suggested the involvement of chemokines in this process. We found functional expression of the lymphoid chemokines CCL19/ELC and CCL21/SLC in CNS venules surrounded by inflammatory cells in brain and spinal cord sections of mice afflicted with EAE suggesting that the lymphoid chemokines CCL19 and CCL21 besides regulating lymphocyte homing to secondary lymphoid tissue might be involved in T lymphocyte migration into the immuneprivileged CNS during immunosurveillance and chronic inflammation. Here, I summarize our current knowledge on the sequence of traffic signals involved in T lymphocyte recruitment across the healthy and inflamed blood-brain and blood-spinal cord barrier based on our in vitro and in vivo investigations.

Entities:  

Mesh:

Year:  2006        PMID: 16550326     DOI: 10.1007/s00702-005-0409-y

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  23 in total

Review 1.  Lymphocyte trafficking and regional immunity.

Authors:  E C Butcher; M Williams; K Youngman; L Rott; M Briskin
Journal:  Adv Immunol       Date:  1999       Impact factor: 3.543

Review 2.  Intravital fluorescence videomicroscopy to study tumor angiogenesis and microcirculation.

Authors:  P Vajkoczy; A Ullrich; M D Menger
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

3.  Alpha4-integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels.

Authors:  P Vajkoczy; M Laschinger; B Engelhardt
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

4.  Encephalitogenic T cells use LFA-1 for transendothelial migration but not during capture and initial adhesion strengthening in healthy spinal cord microvessels in vivo.

Authors:  Melanie Laschinger; Peter Vajkoczy; Britta Engelhardt
Journal:  Eur J Immunol       Date:  2002-12       Impact factor: 5.532

5.  Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

Authors:  T A Yednock; C Cannon; L C Fritz; F Sanchez-Madrid; L Steinman; N Karin
Journal:  Nature       Date:  1992-03-05       Impact factor: 49.962

6.  T-lymphocyte entry into the central nervous system.

Authors:  W F Hickey; B L Hsu; H Kimura
Journal:  J Neurosci Res       Date:  1991-02       Impact factor: 4.164

7.  Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis.

Authors:  B K Kleinschmidt-DeMasters; Kenneth L Tyler
Journal:  N Engl J Med       Date:  2005-06-09       Impact factor: 91.245

8.  Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease.

Authors:  Gert Van Assche; Marc Van Ranst; Raf Sciot; Bénédicte Dubois; Séverine Vermeire; Maja Noman; Jannick Verbeeck; Karel Geboes; Wim Robberecht; Paul Rutgeerts
Journal:  N Engl J Med       Date:  2005-06-09       Impact factor: 91.245

9.  Adhesion molecule phenotype of T lymphocytes in inflamed CNS.

Authors:  B Engelhardt; M T Martin-Simonet; L S Rott; E C Butcher; S A Michie
Journal:  J Neuroimmunol       Date:  1998-04-01       Impact factor: 3.478

10.  Diapedesis of mononuclear cells across cerebral venules during experimental autoimmune encephalomyelitis leaves tight junctions intact.

Authors:  Hartwig Wolburg; Karen Wolburg-Buchholz; Britta Engelhardt
Journal:  Acta Neuropathol       Date:  2004-11-10       Impact factor: 17.088

View more
  114 in total

Review 1.  Immunotherapy for primary brain tumors: no longer a matter of privilege.

Authors:  Peter E Fecci; Amy B Heimberger; John H Sampson
Journal:  Clin Cancer Res       Date:  2014-11-15       Impact factor: 12.531

2.  ["Chronic cerebrospinal venous insufficiency" and multiple sclerosis: critical analysis and first observation in an unselected cohort of MS patients].

Authors:  C Krogias; A Schröder; H Wiendl; R Hohlfeld; R Gold
Journal:  Nervenarzt       Date:  2010-06       Impact factor: 1.214

3.  CXCL12-induced monocyte-endothelial interactions promote lymphocyte transmigration across an in vitro blood-brain barrier.

Authors:  Shumei Man; Barbara Tucky; Anne Cotleur; Judith Drazba; Yukio Takeshita; Richard M Ransohoff
Journal:  Sci Transl Med       Date:  2012-02-01       Impact factor: 17.956

Review 4.  Factors controlling permeability of the blood-brain barrier.

Authors:  Mohammed M A Almutairi; Chen Gong; Yuexian G Xu; Yanzhong Chang; Honglian Shi
Journal:  Cell Mol Life Sci       Date:  2015-09-24       Impact factor: 9.261

5.  Microglial TNF-α-dependent elevation of MHC class I expression on brain endothelium induced by amyloid-beta promotes T cell transendothelial migration.

Authors:  Yi-Ming Yang; De-Shu Shang; Wei-Dong Zhao; Wen-Gang Fang; Yu-Hua Chen
Journal:  Neurochem Res       Date:  2013-08-29       Impact factor: 3.996

6.  Dendritic cell transmigration through brain microvessel endothelium is regulated by MIP-1alpha chemokine and matrix metalloproteinases.

Authors:  Alla L Zozulya; Emily Reinke; Dana C Baiu; Jozsef Karman; Matyas Sandor; Zsuzsanna Fabry
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

7.  Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice.

Authors:  Stephen J Crocker; Jason K Whitmire; Ricardo F Frausto; Parntip Chertboonmuang; Paul D Soloway; J Lindsay Whitton; Iain L Campbell
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

8.  ICAM-1-mediated endothelial nitric oxide synthase activation via calcium and AMP-activated protein kinase is required for transendothelial lymphocyte migration.

Authors:  Roberta Martinelli; Matthew Gegg; Rebecca Longbottom; Peter Adamson; Patric Turowski; John Greenwood
Journal:  Mol Biol Cell       Date:  2008-12-10       Impact factor: 4.138

Review 9.  Immune Cells After Ischemic Stroke Onset: Roles, Migration, and Target Intervention.

Authors:  Lu-Yao Ao; Yun-Yi Yan; Lin Zhou; Cheng-Yuan Li; Wan-Ting Li; Wei-Rong Fang; Yun-Man Li
Journal:  J Mol Neurosci       Date:  2018-10-01       Impact factor: 3.444

Review 10.  TREK-king the blood-brain-barrier.

Authors:  Stefan Bittner; Tobias Ruck; Juncal Fernández-Orth; Sven G Meuth
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-21       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.